搜尋結果
在加入 康希诺 生物之前，宇学峰曾就职于 加拿大 IBEX Biotechnologies Inc. ，任产品研发科学家，从事药用 酶制剂 的研发；1998年加入全球五大疫苗企业之一 赛诺菲巴斯德 （Sanofi Pasteur Limited.），先后担任产品开发部科学家、 细菌疫苗 开发部加拿大分部总监及细菌 ...
Xuefeng YU, co-founder, Chief Executive Officer(CEO) and Chairman of CanSino Biologics. He is primarily responsible for overseeing strategic development, overall operations and management as well as being the major decision-making force of our company. In addition, Dr. Yu is also responsible for managing our commercial operations center.
2022年8月26日 · Xuefeng (学锋） Yu(喻) Understanding angle-resolved polarized Raman scattering from black phosphorus at normal and oblique laser incidences Science Bulletin
Dr. Xuefeng Yu focuses on applied materials and interfaces. He has published over 100 SCI papers in the journals including Nature Communications, Advanced Materials, Advanced Functional...
Yu Xuefeng is co-founder, chairman and CEO of CanSino Biologics, a vaccine supplier. CanSino was founded in Tianjin in 2009. Yu received his doctorate degree in microbiology from McGill...
Xuefeng Yu （喻学锋）. Other names. Professor of Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences. Verified email at siat.ac.cn - Homepage. black phosphorus nanoscience and nanotechnology. Title. Sort. Sort by citations Sort by year Sort by title.
An mRNA Covid-19 vaccine would be a valuable addition to China’s fight against the coronavirus, Chinese vaccine producer CanSino Biologics CEO Yu Xuefeng told the Post.
